$458.60

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI23291_100_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Morpholin-4-yl-acetic acid
Brand Name
Chem Impex
Product Number
23291
CAS
3235-69-6
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
438968
IUPAC Name
2-morpholin-4-ylacetic acid
InChI Key
VIWZVFVJPXTXPA-UHFFFAOYSA-N
SMILES
C1COCCN1CC(=O)O

Application

Morpholin-4-yl-acetic acid is widely utilized in research focused on:

Pharmaceutical Development: This compound serves as a building block in the synthesis of various pharmaceuticals, particularly in the development of drugs targeting neurological disorders due to its ability to cross the blood-brain barrier.

Biochemical Research: It is used in biochemical assays to study enzyme activity and protein interactions, providing insights into cellular processes and potential therapeutic targets.

Polymer Science: Morpholin-4-yl-acetic acid is incorporated into polymer formulations to enhance their properties, such as flexibility and chemical resistance, making it valuable in materials science.

Agricultural Chemistry: The compound is explored for its potential as a plant growth regulator, promoting healthier crop yields and improving resistance to environmental stressors.

Diagnostic Applications: It is being investigated for use in diagnostic agents, particularly in imaging techniques that require specific targeting of biological tissues.

References

How Wastewater Reflects Human Metabolism─Suspect Screening of Pharmaceutical Metabolites in Wastewater Influent

Publication Name: Environmental Science & Technology
Publication Date: 2024-05-24
DOI: 10.1021/acs.est.4c00968

Cannabidiol-Based Prodrugs: Synthesis and Bioevaluation

Publication Name: ACS Medicinal Chemistry Letters
Publication Date: 2024-01-16
DOI: 10.1021/acsmedchemlett.3c00461

S113 | SWISSPHARMA24 | 2024 Swiss Pharmaceutical List with Metabolites

Publication Date: 2024
DOI: 10.5281/zenodo.10501043

Synthesis of macrocyclic α-ketoamide as a selective and reversible immunoproteasome inhibitor

Publication Name: Medicinal Chemistry Research
Publication Date: 2021-01-11
DOI: 10.1007/s00044-020-02678-2